We are live on ! Find out more
SCA

Spearhead Capital Advisors Portfolio holdings

AUM $92.3M
1-Year Est. Return 18.16%
This Fund
S&P 500
This Quarter Est. Return
-15.81%
1 Year Est. Return
-18.16%
3 Year Est. Return
+25.24%
5 Year Est. Return
+54.04%
10 Year Est. Return
AUM
$670M
AUM Growth
-$137M
Cap. Flow
-$2.06M
Cap. Flow %
-0.31%
Top 10 Hldgs %
30.46%
Holding
217
New
24
Increased
35
Reduced
100
Closed
37

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$11.5M
2
COIN icon
Coinbase
COIN
+$7.88M
3
META icon
Meta Platforms (Facebook)
META
+$4.36M
4
AMZN icon
Amazon
AMZN
+$2.56M
5
DIS icon
Walt Disney
DIS
+$2.43M

Sector Composition

Rank Sector Weight
1 Technology 15.61%
2 Healthcare 12.77%
3 Financials 10.61%
4 Consumer Staples 9.53%
5 Consumer Discretionary 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEA icon
126
Vanguard FTSE Developed Markets ETF
VEA
$229B
$301K 0.04%
+7,378
New +$328K
SHV icon
127
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$300K 0.04%
2,726
PTCT icon
128
PTC Therapeutics
PTCT
$5.68B
$298K 0.04%
7,448
-105
-1% -$3.68K
ARI
129
Apollo Commercial Real Estate
ARI
$867M
$297K 0.04%
28,463
+11,327
+66% +$139K
VCSH icon
130
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$291K 0.04%
3,822
-381
-9% -$29.3K
AXNX
131
DELISTED
Axonics, Inc. Common Stock
AXNX
$291K 0.04%
5,133
-71
-1% -$3.89K
FIDU icon
132
Fidelity MSCI Industrials Index ETF
FIDU
$2.3B
$280K 0.04%
6,184
VWOB icon
133
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$271K 0.04%
4,414
-103
-2% -$6.67K
SILK
134
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$270K 0.04%
7,427
-109
-1% -$3.96K
DVAX
135
DELISTED
Dynavax Technologies
DVAX
$264K 0.04%
20,973
-290
-1% -$3.08K
CRWD icon
136
CrowdStrike
CRWD
$194B
$263K 0.04%
6,244
-92
-1% -$4.17K
QDEL icon
137
QuidelOrtho
QDEL
$1.14B
$262K 0.04%
2,695
+263
+11% +$26.8K
MRNA icon
138
Moderna
MRNA
$21.8B
$256K 0.04%
1,795
-480
-21% -$68.6K
CERS icon
139
Cerus
CERS
$433M
$254K 0.04%
48,057
-713
-1% -$3.56K
RARE icon
140
Ultragenyx Pharmaceutical
RARE
$2.45B
$252K 0.04%
4,232
-58
-1% -$3.57K
SUB icon
141
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
$252K 0.04%
+2,412
New +$251K
NVDA icon
142
NVIDIA
NVDA
$4.86T
$250K 0.04%
16,500
-5,600
-25% -$106K
STAA icon
143
STAAR Surgical
STAA
$1.21B
$249K 0.04%
3,508
-52
-1% -$3.35K
CLFD icon
144
Clearfield
CLFD
$411M
$248K 0.04%
3,999
-57
-1% -$3.35K
NOW icon
145
ServiceNow
NOW
$115B
$246K 0.04%
2,585
-40
-2% -$3.81K
VEEV icon
146
Veeva Systems
VEEV
$33.1B
$246K 0.04%
1,242
-20
-2% -$3.68K
MPWR icon
147
Monolithic Power Systems
MPWR
$70.1B
$244K 0.04%
635
-9
-1% -$3.8K
SRPT icon
148
Sarepta Therapeutics
SRPT
$1.57B
$244K 0.04%
3,259
-50
-2% -$3.68K
ESGE icon
149
iShares ESG Aware MSCI EM ETF
ESGE
$6.58B
$241K 0.04%
7,465
+62
+0.8% +$2.1K
MED icon
150
Medifast
MED
$109M
$241K 0.04%
1,336
-21
-2% -$3.76K

Similar funds

Spearhead Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Spearhead Capital Advisors held 217 positions worth $670M, down 17% from $808M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Spearhead Capital Advisors's Q2 2022 filing shows 24 new, 35 increased, 100 reduced and 37 closed positions. Its largest new stake was Moody's: 3,074 shares worth $836K. The largest sale was iShares Core S&P 500 ETF, an estimated $7.45M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Spearhead Capital Advisors's largest Q2 2022 buy was Moody's: 3,074 shares worth $836K.
  • Spearhead Capital Advisors added most to Invesco QQQ Trust in Q2 2022, an estimated $11.5M increase.
  • Spearhead Capital Advisors's biggest Q2 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $7.45M.
  • Spearhead Capital Advisors fully exited Tesla in Q2 2022, selling an estimated $4.79M.
  • Spearhead Capital Advisors's ten largest holdings make up 30% of its $670M portfolio in Q2 2022.
  • Spearhead Capital Advisors opened 24 new positions and closed 37 in Q2 2022.
  • Spearhead Capital Advisors's portfolio value fell 17% quarter-over-quarter to $670M.

Based on Spearhead Capital Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.